🔎 Trials Near Me

Почетна › Метастатски карцином › Оклахома

Kliničke studije za Метастатски карцином u državi Оклахома

18 studija za Метастатски карцином traži učesnike na lokacijama u državi Оклахома.

Gradovi u državi Оклахома

Zvanični tekst studije (na engleskom)

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

  • University of Oklahoma Health Sciences Center, Oklahoma City
Тражи се учесникФаза 2
Сви узрасти · Оба пола · Ажурирано 12. 11. 2026. · NCT05564377

Modified FOLFIRINOX and Pentamidine in Advanced and Metastatic Pancreatic Cancer

  • University of Oklahoma Health Campus, Oklahoma City
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 6. 11. 2026. · NCT07829185

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

  • University of Oklahoma Health Sciences Center, Stephenson Cancer Center, Oklahoma City
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07213804

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

  • University of Oklahoma - Health Sciences Center, Oklahoma City
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT05614739

Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers

  • University of Oklahoma Health Sciences Center, Oklahoma City
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT05803382

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

  • Stephenson Cancer Center, Oklahoma City
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 22. 10. 2026. · NCT04657068

Collection and Storage of Tissue and Blood Samples From Patients With Cancer

  • Mercy Hospital Oklahoma City, Oklahoma City
Тражи се учесникОпсервациона студија
2 Months · Оба пола · Ажурирано 22. 10. 2026. · NCT02474160

Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)

  • University of Oklahoma Health Sciences Center, Oklahoma City
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 20. 10. 2026. · NCT06311214

BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)

  • Avenzo Therapeutics Recruiting Site, Oklahoma City
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 5. 10. 2026. · NCT07193511

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

  • University of Oklahoma, Oklahoma City
Тражи се учесникФаза 1/2
Узраст 12 и старији · Оба пола · Ажурирано 2. 10. 2026. · NCT04585750

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

  • University of Oklahoma, Oklahoma City
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 22. 9. 2026. · NCT06128551

Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes

  • University of Oklahoma Health Sciences Center, Oklahoma City
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 3. 8. 2026. · NCT05687110

Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness

  • University of Oklahoma Health Sciences Center, Oklahoma City
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 31. 7. 2026. · NCT05691491

Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)

  • Sarah Cannon Research Institute University of Oklahoma, Oklahoma City
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 19. 5. 2026. · NCT05431270

Circulating Tumor DNA Response In Urothelial Cancer

  • OU Health Stephenson Cancer Center, Oklahoma City
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 2. 2. 2026. · NCT07183319

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Tulsa
Тражи се учесникОпсервациона студија
Сви узрасти · Оба пола · Ажурирано 28. 10. 2025. · NCT03452774

Spine Radiosurgery for Symptomatic Metastatic Neoplasms

  • OU Health Stephenson Cancer Center, Oklahoma City
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 20. 10. 2025. · NCT05617716

A Study of NX-1607 in Adults With Advanced Malignancies

  • University of Oklahoma, Oklahoma City
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 9. 9. 2025. · NCT05107674

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.